🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This double-blind 8 week study will evaluate dose response, efficacy (blood...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-06
Trial ID
NCT01150357
Treatments Being Tested
Summary In patients with prostate cancer (PC) who have only biochemically ...
Status
Unknown
Location
Copenhagen University hospital, Rigshospitalet
Start Date
2009-02
Trial ID
NCT03119857
Treatments Being Tested
The primary endpoint is to determine if ECP induces a decrease in % of tumo...
Status
Recruiting
Location
Emory University School of Medicine
Start Date
2023-04-04
Trial ID
NCT05157581
Treatments Being Tested
(Neo)adjuvant treatment approaches and outcomes...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-06-30
Trial ID
NCT05939128
Hospitalization for elective knee or hip replacement surgery presents an ou...
Status
Completed
Location
New York University School of Medicine
Start Date
2019-01-15
Trial ID
NCT03673228
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
An Advanced Virtual Exercise Environment Device (AVEED) has been developed ...
Status
Completed
Location
Univerisity of Alabama at Birmingham
Start Date
2017-02-10
Trial ID
NCT02990507
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested